Results 171 to 180 of about 403,304 (294)

Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances

open access: yesClinical, Cosmetic and Investigational Dermatology
Ting Song,1,2 Shun Guo,1,2 Jia Liu,1,2 Cheng Tan,1,2 Yue Shi1,21Department of Dermatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People’s Republic of China; 2Department of Dermatology, Jiangsu Province Hospital ...
Song T, Guo S, Liu J, Tan C, Shi Y
doaj  

Lost and found in translation: the value of the human imiquimod model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Topical imiquimod (IMQ), a Toll‐like receptor (TLR) 7 agonist, induces transient cutaneous inflammation and is widely used in preclinical research as a ‘psoriasis‐like’ mouse model. However, accumulating evidence indicates substantial divergence between IMQ‐driven biology and human plaque psoriasis pathogenesis.
Anouk C. Meijs   +6 more
wiley   +1 more source

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis

open access: yesPsoriasis: Targets and Therapy
Yanhua Liang,1 Baoqing Deng,2 Epipode Ntawuyamara,3 Hervé Bachelez,4 Fuxi Wang,5 Hao Zhang,6 Zhenying Zhang,7 Zhengfeng Li,7 Lin Dang,8 Yajie Wang,1 Xianbiao Zou,9 Li Wang,10 Dejian Duan,11 Hongxiang Chen,12 Wenjun Zheng,13 Hui Huang,14 Min Zhang,15 ...
Liang Y   +22 more
doaj  

HLA‐B*15:21 carrier status is a susceptibility factor of carbamazepine‐induced nonimmediate cutaneous adverse reactions in HLA‐B*15:02‐negative patients: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
After HLA‐B*15:02 screening, the residual risk of carbamazepine‐induced nonimmediate cutaneous adverse reactions is 0.059. Among these HLA‐B*15:02‐negative cases, HLA‐B*15:11 and HLA‐B*15:21 carrier status significantly increases the risk of carbamazepine‐induced nonimmediate cADR.
Warit Ruanglertboon   +11 more
wiley   +1 more source

Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis

open access: yesDrug Design, Development and Therapy
Lei Shi,1 Siying Li,1 Xiaodong Yao,1 Zijian Zhang,2 Qinyi Dong,2 Han Zhang,1 Xinman Wang,1 Jiahao Bai,1 Huiyan Han,1 Xiaoyi Fu,2 Kaili Zheng,1 Lili Liang1,2 1The Cosmetic and Plastic Surgery, Department of Shanxi Provincial People’ s Hospital, Shanxi ...
Shi L   +11 more
doaj  

Long-Term Effectiveness and Drug Survival of Risankizumab in Elderly Patients with Moderate-to-Severe Plaque Psoriasis: A Real-World Experience. [PDF]

open access: yesClin Cosmet Investig Dermatol
Orsini D   +19 more
europepmc   +1 more source

Lithium‐related adverse drug reactions in children: A case–control study comparing lithium to second‐generation antipsychotics in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling   +8 more
wiley   +1 more source

Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study

open access: yesJournal of Inflammation Research
Zhiqiang Cao,1,* Bin Peng,1,* Zonghao Li,2 Ruiqi Li,1 Ruitao Fan,1 Baibing Mi,2 Bingjie Li,1 Xiangjin Song,1 Jing Shi,1 Songmei Geng1 1Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated of Xi’an Jiaotong ...
Cao Z   +9 more
doaj  

Understanding Gender Wage Disparities in Dermatology. [PDF]

open access: yesJMIR Dermatol
Duffle D   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy